42 USC 300ee-1: Establishment of office with respect to minority health and acquired immune deficiency syndrome

42 USC 300ee-1: Establishment of office with respect to minority health and acquired immune deficiency syndrome Text contains those laws in effect on January 7, 2011

From Title 42-THE PUBLIC HEALTH AND WELFARECHAPTER 6A-PUBLIC HEALTH SERVICESUBCHAPTER XXIII-PREVENTION OF ACQUIRED IMMUNE DEFICIENCY SYNDROME

Jump To: Source CreditCodificationAmendmentsMiscellaneous

§300ee–1. Establishment of office with respect to minority health and acquired immune deficiency syndrome

The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall establish an office for the purpose of ensuring that, in carrying out the duties of the Secretary with respect to prevention of acquired immune deficiency syndrome, the Secretary develops and implements prevention programs targeted at minority populations and provides appropriate technical assistance in the implementation of such programs.

( Pub. L. 100–607, title II, §252, Nov. 4, 1988, 102 Stat. 3108 ; Pub. L. 102–531, title III, §312(e)(2), Oct. 27, 1992, 106 Stat. 3506 .)

Codification

Section was enacted as part of the AIDS Amendments of 1988 and as part of the Health Omnibus Programs Extension of 1988, and not as part of the Public Health Service Act which comprises this chapter.

Amendments

1992-Pub. L. 102–531 substituted "Centers for Disease Control and Prevention" for "Centers for Disease Control".

Requirement of Study With Respect to Minority Health and Acquired Immune Deficiency Syndrome

Section 251 of Pub. L. 100–607, as amended by Pub. L. 100–690, title II, §2602(b), Nov. 18, 1988, 102 Stat. 4234 , provided that:

"(a) In General.-The Secretary of Health and Human Services, acting through the Director of the Office of Minority Health, shall conduct a study for the purpose of determining-

"(1) the level of knowledge within minority communities concerning acquired immune deficiency syndrome, the risks of the transmission of the etiologic agent for such syndrome, and the means of reducing such risk; and

"(2) the effectiveness of Federal, State, and local prevention programs with respect to acquired immune deficiency syndrome in minority communities.

"(b) Report.-The Secretary shall, not later than 12 months after the date of the enactment of this title [Nov. 4, 1988], complete the study required in subsection (a) and submit to the Congress a report describing the findings made as a result of the study."